Lexatumumab, the engineered antibody, presents remarkable promise in the battle against tumor illness. This new drug uniquely attaches to the HER3 receptor, that is frequently overexpressed in various tumoral forms. https://bookmark-dofollow.com/story28257209/lexatumumab-a-promising-therapy-for-tumors